Form 8-K - Current report:
SEC Accession No. 0001193125-24-199382
Filing Date
2024-08-13
Accepted
2024-08-13 07:05:33
Documents
42
Period of Report
2024-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d881755d8k.htm   iXBRL 8-K 34803
2 EX-99.1 d881755dex991.htm EX-99.1 101853
3 EX-99.2 d881755dex992.htm EX-99.2 33266
7 GRAPHIC g881755ex99_2s10g1.jpg GRAPHIC 88292
8 GRAPHIC g881755ex99_2s11g1.jpg GRAPHIC 104972
9 GRAPHIC g881755ex99_2s12g1.jpg GRAPHIC 90894
10 GRAPHIC g881755ex99_2s13g1.jpg GRAPHIC 86471
11 GRAPHIC g881755ex99_2s14g1.jpg GRAPHIC 101190
12 GRAPHIC g881755ex99_2s15g1.jpg GRAPHIC 76174
13 GRAPHIC g881755ex99_2s16g1.jpg GRAPHIC 92572
14 GRAPHIC g881755ex99_2s17g1.jpg GRAPHIC 89249
15 GRAPHIC g881755ex99_2s18g1.jpg GRAPHIC 78972
16 GRAPHIC g881755ex99_2s19g1.jpg GRAPHIC 74801
17 GRAPHIC g881755ex99_2s1g1.jpg GRAPHIC 51133
18 GRAPHIC g881755ex99_2s20g1.jpg GRAPHIC 94055
19 GRAPHIC g881755ex99_2s21g1.jpg GRAPHIC 86663
20 GRAPHIC g881755ex99_2s22g1.jpg GRAPHIC 99540
21 GRAPHIC g881755ex99_2s23g1.jpg GRAPHIC 89108
22 GRAPHIC g881755ex99_2s24g1.jpg GRAPHIC 95754
23 GRAPHIC g881755ex99_2s25g1.jpg GRAPHIC 91310
24 GRAPHIC g881755ex99_2s26g1.jpg GRAPHIC 116380
25 GRAPHIC g881755ex99_2s2g1.jpg GRAPHIC 204702
26 GRAPHIC g881755ex99_2s3g1.jpg GRAPHIC 158467
27 GRAPHIC g881755ex99_2s4g1.jpg GRAPHIC 124606
28 GRAPHIC g881755ex99_2s5g1.jpg GRAPHIC 90739
29 GRAPHIC g881755ex99_2s6g1.jpg GRAPHIC 115252
30 GRAPHIC g881755ex99_2s7g1.jpg GRAPHIC 101725
31 GRAPHIC g881755ex99_2s8g1.jpg GRAPHIC 83284
32 GRAPHIC g881755ex99_2s9g1.jpg GRAPHIC 78827
33 GRAPHIC g881755g0813072657147.jpg GRAPHIC 2666
  Complete submission text file 0001193125-24-199382.txt   3860458

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20240813.xsd EX-101.SCH 2869
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20240813_lab.xml EX-101.LAB 17236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20240813_pre.xml EX-101.PRE 10825
44 EXTRACTED XBRL INSTANCE DOCUMENT d881755d8k_htm.xml XML 3506
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37465 | Film No.: 241198736
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)